Advancements in medical technology and the aging of the baby boomer generation are leading to a rapid expansion in the use of medical devices, a market that is predicted to double over the next ten years. While these mechanical products bring substantial benefits to patient care, they inadvertently carry the risk of severe complications such as infection, thrombosis, and restenosis. 

Between the looming explosion in the number of implants and industry's ineffective response to the need for improved surface technology, the market is ready and waiting for the introduction of next-generation devices that can improve the quality and reliability of patient outcomes. Semprus has developed a scalable technology platform which initially targets hospital-acquired infections, but can be extended to address thrombosis, restenosis, and other device interactions.